These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21969830)

  • 1. The blood compatibilities of blood purification membranes and other materials developed in Japan.
    Abe T; Kato K; Fujioka T; Akizawa T
    Int J Biomater; 2011; 2011():375390. PubMed ID: 21969830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance of technical management of dialysis water and dialysis fluid for the Japan Association for Clinical Engineering Technologists.
    Kawasaki T; Uchino J; Shinoda T; Kawanishi H;
    Blood Purif; 2009; 27 Suppl 1():41-9. PubMed ID: 19556763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach for blood purification: mixed-matrix membranes combining diffusion and adsorption in one step.
    Tijink MS; Wester M; Sun J; Saris A; Bolhuis-Versteeg LA; Saiful S; Joles JA; Borneman Z; Wessling M; Stamatialis DF
    Acta Biomater; 2012 Jul; 8(6):2279-87. PubMed ID: 22406909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of water purification in the central dialysis fluid delivery system: validation and parametric method.
    Tomo T; Shinoda T
    Blood Purif; 2009; 27 Suppl 1():36-40. PubMed ID: 19556762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in therapeutic application of engineered blood purification materials for kidney disease.
    Gao C; Zhang Q; Yang Y; Li Y; Lin W
    Biomater Res; 2022 Feb; 26(1):5. PubMed ID: 35120554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis membranes for blood purification.
    Sakai K
    Front Med Biol Eng; 2000; 10(2):117-29. PubMed ID: 10898241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of ultrapure dialysate in Japan--clinical usefulness and short-term future.
    Sato T; Kurosawa A; Kurihara T; Kurosawa T
    Blood Purif; 2004; 22 Suppl 2():55-9. PubMed ID: 15655325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biocompatibility of synthetic membrane for blood purification therapy].
    Akizawa T; Nabeshima K; Kawabe S
    Nihon Rinsho; 1991 Dec; 49 Suppl():53-60. PubMed ID: 1808312
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of biocompatibility in polysulfone dialysis membranes with different sterilization.
    Togo K; Yamamoto M; Ono T; Imai M; Akiyama K; Ebine K; Yamashita AC
    Hemodial Int; 2018 Oct; 22(S2):S10-S14. PubMed ID: 30411467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of protein-A-based affinity membranes for antibody purification.
    Uzun L; Türkmen D; Karakoç V; Yavuz H; Denizli A
    J Biomater Sci Polym Ed; 2011; 22(17):2325-41. PubMed ID: 21092422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminology and classification of blood purification in critical care in Japan.
    Kawanishi H
    Contrib Nephrol; 2010; 166():11-20. PubMed ID: 20472987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of membrane materials for blood purification devices in critical care.
    Yamashita AC; Tomisawa N
    Transfus Apher Sci; 2009 Feb; 40(1):23-31. PubMed ID: 19167928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient safety technology for microadsorbent systems in extracorporeal blood purification.
    Falkenhagen D; Strobl W; Hartmann J; Schrefl A; Linsberger I; Kellner KH; Aussenegg F; Leitner A
    Artif Organs; 2002 Feb; 26(2):84-90. PubMed ID: 11879234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 2-microglobulin removal by synthetic dialysis membranes. Mechanisms and kinetics of the molecule.
    Ronco C; Heifetz A; Fox K; Curtin C; Brendolan A; Gastaldon F; Crepaldi C; Fortunato A; Pietribasi G; Caberlotto A; Brunello A; Milan Manani S; Zanella M; La Greca G
    Int J Artif Organs; 1997 Mar; 20(3):136-43. PubMed ID: 9151148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will the "short dialysis" of the eighties be adequate?
    Jacobs C
    Adv Nephrol Necker Hosp; 1989; 18():273-96. PubMed ID: 2493718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility of the dialysis membrane.
    Takemoto Y; Naganuma T; Yoshimura R
    Contrib Nephrol; 2011; 168():139-145. PubMed ID: 20938134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro study of dual layer mixed matrix hollow fiber membranes for outside-in filtration of human blood plasma.
    Ter Beek OEM; van Gelder MK; Lokhorst C; Hazenbrink DHM; Lentferink BH; Gerritsen KGF; Stamatialis D
    Acta Biomater; 2021 Mar; 123():244-253. PubMed ID: 33450414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefits of predilution on-line hemodiafiltration.
    Tsuchida K; Minakuchi J
    Blood Purif; 2013; 35 Suppl 1():18-22. PubMed ID: 23466373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended characterization of a new class of membranes for blood purification: the high cut-off membranes.
    Boschetti-de-Fierro A; Voigt M; Storr M; Krause B
    Int J Artif Organs; 2013 Jul; 36(7):455-63. PubMed ID: 23661558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.